Takeda's Entyvio holds onto IBD market share despite threat from AbbVie's Skyrizi 31.07.2024 22:52 Fiercepharma.com Takeda's Entyvio holds onto IBD market share despite threat from AbbVie's Skyrizi zbecker Wed, 07/31/2024 - 15:52
